RadNet, Inc.'s revenue has grown 14% a year over three years, and grown 13% a year over five. Revenue growth, 3-year annual rate: +14% (Diagnostics & Research median +8.6%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

RDNTRadNet, Inc.

Healthcare

$70.35-9.1% 1Y

$70.35

$51.8752 weeks$84.48

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though revenue growing +19% year on year.

1 good, 1 neutral, 1 without data

Revenue trend+19% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Margin direction−0.3 points operating

Trailing-twelve-month operating margin, 3.1% now against 3.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 78% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RDNT growing?

RadNet, Inc.'s revenue has grown 14% a year over three years, and grown 13% a year over five.

+14%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.6% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›